Stevens Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-15,778
| Closed | -$1.34M | – | 796 |
|
|
2018
Q4 | $1.34M | Buy |
+15,778
| New | +$1.34M | 0.07% | 322 |
|
|
2018
Q3 | – | Sell |
-5,009
| Closed | -$647K | – | 857 |
|
|
2018
Q2 | $647K | Buy |
+5,009
| New | +$647K | 0.02% | 500 |
|
|
2017
Q1 | – | Sell |
-11,596
| Closed | -$735K | – | 991 |
|
|
2016
Q4 | $735K | Buy |
+11,596
| New | +$735K | 0.03% | 492 |
|
|
2015
Q1 | – | Sell |
-14,635
| Closed | -$486K | – | 1119 |
|
|
2014
Q4 | $486K | Buy |
14,635
+3,587
| +32% | +$119K | 0.02% | 590 |
|
|
2014
Q3 | $324K | Sell |
11,048
-17,731
| -62% | -$520K | 0.01% | 712 |
|
|
2014
Q2 | $1.12M | Buy |
28,779
+16,564
| +136% | +$643K | 0.03% | 478 |
|
|
2014
Q1 | $513K | Buy |
+12,215
| New | +$513K | 0.01% | 657 |
|